InsiderTrades.com logo
Warning: The Last Value Play Gone After August?
From Oxford Club   |   Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

PHAS Insider Trading (PhaseBio Pharmaceuticals)

Insider Ownership Percentage: 9.00%
Insider Buying (Last 12 Months): $30,000.00
Insider Selling (Last 12 Months): $13,665.42

PhaseBio Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at PhaseBio Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PhaseBio Pharmaceuticals Share Price & Price History

Current Price: $0.80
Price Change: ▼ Price Decrease of -0.04 (-4.75%)
As of 05/20/2022 01:00 AM ET

This chart shows the closing price history over time for PHAS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How You Should Be Choosing Your Stocks
From Vantage Point   |   Ad
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

PhaseBio Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Glen BurkhardtVPSell5,766$2.37$13,665.42View SEC Filing Icon  
8/18/2021Clay ThorpDirectorBuy10,000$3.00$30,000.00View SEC Filing Icon  
5/20/2021Glen BurkhardtVPSell3,811$3.29$12,538.193,811View SEC Filing Icon  
12/3/2020Edmund HarriganDirectorBuy6,000$4.12$24,720.006,000View SEC Filing Icon  
11/24/2020Clay ThorpDirectorBuy5,000$3.60$18,000.00
11/23/2020Glen BurkhardtVPSell3,497$3.45$12,064.653,497View SEC Filing Icon  
7/1/2019Clay ThorpDirectorSell2,908$14.00$40,712.00View SEC Filing Icon  
6/18/2019Clay ThorpDirectorSell400$14.00$5,600.00View SEC Filing Icon  
See Full Table
Warning: The Last Value Play Gone After August?
From Oxford Club   |   Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

SEC Filings (Institutional Ownership Changes) for PhaseBio Pharmaceuticals (NASDAQ:PHAS)

57.43% of PhaseBio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PHAS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

PhaseBio Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Virtu Financial LLC31,305$41K0.0%N/A0.064%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP2,613,825$3.45M0.1%+1.3%5.368%Search for SEC Filing on Google Icon
5/17/2022Endurant Capital Management LP243,795$0.32M0.1%-32.3%0.501%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP1,674,690$2.21M0.0%-41.6%3.439%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC89,300$0.12M0.0%N/A0.183%Search for SEC Filing on Google Icon
5/13/2022Blair William & Co. IL35,696$47K0.0%+56.0%0.073%Search for SEC Filing on Google Icon
5/11/2022Towercrest Capital Management1,051,940$1.39M0.3%N/A2.160%Search for SEC Filing on Google Icon
5/10/2022MAI Capital Management1,418,279$1.87M0.0%N/A2.913%Search for SEC Filing on Google Icon
5/5/2022Resources Investment Advisors LLC.113,150$0.15M0.0%+48.6%0.232%Search for SEC Filing on Google Icon
5/3/2022Platform Technology Partners242,473$0.32M0.2%-3.7%0.498%Search for SEC Filing on Google Icon
2/23/2022Resources Investment Advisors LLC.76,150$0.20M0.0%-13.6%0.158%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.685,397$1.79M0.0%+32.0%1.425%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP362,170$0.95M0.0%+65.5%0.753%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC130,328$0.34M0.0%-56.5%0.271%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.11,796$31K0.0%-85.0%0.025%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC37,452$98K0.0%+169.3%0.078%Search for SEC Filing on Google Icon
2/14/2022IPG Investment Advisors LLC28,900$76K0.0%N/A0.060%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC378,611$0.99M0.2%-37.2%0.787%Search for SEC Filing on Google Icon
2/11/2022Northeast Financial Consultants Inc37,760$99K0.0%N/A0.079%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC325,395$0.85M0.0%+2,492.8%0.677%Search for SEC Filing on Google Icon
2/8/2022Raymond James & Associates15,500$40K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/1/2022Platform Technology Partners251,723$0.66M0.3%+9.8%0.523%Search for SEC Filing on Google Icon
1/14/2022Spire Wealth Management253,723$0.66M0.0%N/A0.528%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC27,083$84K0.0%+29.8%0.056%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP4,024,658$12.52M0.0%-11.3%8.377%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC299,816$0.93M0.0%+44.5%0.624%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC13,907$43K0.0%-65.6%0.029%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC13,137$41K0.0%-31.3%0.027%Search for SEC Filing on Google Icon
11/15/2021Pura Vida Investments LLC27,944$87K0.0%N/A0.058%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP218,877$0.68M0.0%N/A0.456%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley149,162$0.46M0.0%+15.6%0.310%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP300,000$0.93M0.1%N/A0.624%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP263,172$0.82M0.0%N/A0.548%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC100,566$0.31M0.0%N/A0.209%Search for SEC Filing on Google Icon
11/12/2021Johnson & Johnson1,607,044$5M0.4%N/A3.342%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC43,867$0.14M0.0%N/A0.091%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC280,589$0.87M0.0%+43.3%0.584%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.30,616$95K0.0%-40.3%0.064%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.519,359$1.62M0.0%+6.6%1.081%Search for SEC Filing on Google Icon
11/9/2021Candriam Luxembourg S.C.A.1,081,258$3.36M0.0%+74.6%2.251%Search for SEC Filing on Google Icon
11/5/2021Resources Investment Advisors LLC.88,150$0.27M0.0%+68.1%0.183%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC10,254$38K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/27/2021Endurant Capital Management LP2,129,709$7.92M2.2%-1.6%4.433%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley129,081$0.48M0.0%+31.1%0.269%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC207,543$0.77M0.0%N/A0.457%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC40,564$0.15M0.0%+13.0%0.089%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC40,384$0.15M0.0%+1,382.5%0.089%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC88,600$0.33M0.0%-21.3%0.195%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC20,867$78K0.0%-81.4%0.046%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE7,065$26K0.0%-68.1%0.016%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC19,132$71K0.0%N/A0.042%Search for SEC Filing on Google Icon
8/16/2021Occudo Quantitative Strategies LP14,915$55K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley129,081$0.48M0.0%+31.1%0.284%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.17,190$64K0.0%-47.0%0.038%Search for SEC Filing on Google Icon
8/16/2021State Street Corp79,078$0.29M0.0%-77.1%0.174%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd91,200$0.34M0.1%N/A0.201%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.51,297$0.19M0.0%+294.3%0.113%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp64,481$0.24M0.0%-61.4%0.142%Search for SEC Filing on Google Icon
8/13/2021Stifel Financial Corp262,693$0.98M0.0%+6.8%0.578%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC195,860$0.73M0.0%-18.9%0.431%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,868,664$6.95M0.0%+18.9%4.112%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.76,606$0.29M0.0%+8.1%0.169%Search for SEC Filing on Google Icon
8/12/2021Blair William & Co. IL17,000$63K0.0%-84.0%0.037%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC69,800$0.26M0.0%N/A0.154%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.487,024$1.81M0.0%-60.1%1.072%Search for SEC Filing on Google Icon
8/9/2021Resources Investment Advisors LLC.52,450$0.20M0.0%N/A0.115%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners229,373$0.85M0.4%N/A0.505%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP186,031$0.69M0.1%-11.7%0.409%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC112,117$0.39M0.0%N/A0.247%Search for SEC Filing on Google Icon
5/18/2021RA Capital Management L.P.2,850,000$9.86M0.1%N/A6.272%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley98,461$0.34M0.0%-9.2%0.217%Search for SEC Filing on Google Icon
5/17/2021Endurant Capital Management LP2,163,518$7.49M2.0%N/A4.761%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP1,553,974$5.38M0.1%+18.2%3.420%Search for SEC Filing on Google Icon
5/17/2021DAFNA Capital Management LLC603,042$2.09M0.5%+88.1%1.327%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC80,353$0.28M0.0%-18.7%0.177%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.750,000$2.60M0.2%N/A1.650%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC400,000$1.38M0.2%N/A0.880%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp245,887$0.85M0.0%+17.0%0.541%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC12,754$45K0.0%+159.1%0.028%Search for SEC Filing on Google Icon
5/13/2021Alpine Global Management LLC51,891$0.18M0.0%N/A0.114%Search for SEC Filing on Google Icon
5/13/2021Blair William & Co. IL106,500$0.37M0.0%+57.8%0.234%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC241,513$0.84M0.0%+4.1%0.531%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.70,874$0.25M0.0%+72.8%0.156%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG8,150$28K0.0%+523.1%0.018%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP210,656$0.73M0.1%+50.1%0.464%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,219,125$4.22M0.0%+2.1%4.141%Search for SEC Filing on Google Icon
5/7/2021Spire Wealth Management50,065$0.17M0.0%N/A0.170%Search for SEC Filing on Google Icon
5/6/2021Altium Capital Management LP775,000$2.68M0.7%N/A2.632%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC28,821$97K0.0%N/A0.098%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.41,006$0.14M0.0%+616.6%0.140%Search for SEC Filing on Google Icon
2/16/2021ETF Managers Group LLC14,283$50K0.0%-13.1%0.049%Search for SEC Filing on Google Icon
2/12/2021Stifel Financial Corp210,125$0.71M0.0%+11.9%0.716%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers10,492$35K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC83,400$0.28M0.0%N/A0.284%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN24,792$83K0.0%+17.8%0.084%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp36,965$0.13M0.0%-7.0%0.126%Search for SEC Filing on Google Icon
2/9/2021Blair William & Co. IL67,500$0.23M0.0%N/A0.230%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.1,193,607$4.01M0.0%+5.2%4.065%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP140,341$0.47M0.1%-9.1%0.478%Search for SEC Filing on Google Icon
11/30/2020Platform Technology Partners92,950$0.33M0.2%+72.2%0.317%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
PhaseBio Pharmaceuticals logo
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania.
Read More on PhaseBio Pharmaceuticals

Today's Range

Now: $0.80
Low: $0.75
High: $0.88

50 Day Range

MA: $1.18
Low: $0.80
High: $1.68

52 Week Range

Now: $0.80
Low: $0.75
High: $4.24

Volume

1,056,101 shs

Average Volume

620,722 shs

Market Capitalization

$39.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Who are the company insiders with the largest holdings of PhaseBio Pharmaceuticals?

PhaseBio Pharmaceuticals' top insider shareholders include:
  1. Edmund Harrigan (Director)
  2. Glen Burkhardt (VP)
  3. Clay Thorp (Director)
Learn More about top insider investors at PhaseBio Pharmaceuticals.

Who are the major institutional investors of PhaseBio Pharmaceuticals?

PhaseBio Pharmaceuticals' top institutional shareholders include:
  1. Rock Springs Capital Management LP — 5.37%
  2. Wellington Management Group LLP — 3.44%
  3. MAI Capital Management — 2.91%
  4. Towercrest Capital Management — 2.16%
  5. Endurant Capital Management LP — 0.50%
  6. Platform Technology Partners — 0.50%
Learn More about top institutional investors of PhaseBio Pharmaceuticals stock.

Which major investors are selling PhaseBio Pharmaceuticals stock?

In the previous quarter, PHAS stock was sold by these institutional investors:
  1. Wellington Management Group LLP
  2. Endurant Capital Management LP
  3. Platform Technology Partners
  4. Simplex Trading LLC

Which major investors are buying PhaseBio Pharmaceuticals stock?

During the last quarter, PHAS stock was purchased by institutional investors including:
  1. MAI Capital Management
  2. Towercrest Capital Management
  3. Renaissance Technologies LLC
  4. Resources Investment Advisors LLC.
  5. Rock Springs Capital Management LP
  6. Virtu Financial LLC
  7. Blair William & Co. IL
Within the last year, these company insiders have bought PhaseBio Pharmaceuticals stock:
  1. Edmund Harrigan (Director)
  2. Glen Burkhardt (VP)
Learn More investors buying PhaseBio Pharmaceuticals stock.
Warning: The Last Value Play Gone After August?
From Oxford Club   |   Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.